Toronto Dominion Bank’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Toronto Dominion Bank’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-110,900	Closed	-$1.14M	–	1945
2023 Q2	$1.14M	Hold	110,900	–	–	﹤0.01%	958
2023 Q1	$1.12M	Hold	110,900	–	–	﹤0.01%	968
2022 Q4	$1.11M	Hold	110,900	–	–	﹤0.01%	1022
2022 Q3	$1.07M	Hold	110,900	–	–	﹤0.01%	1053
2022 Q2	$1.07M	Hold	110,900	–	–	﹤0.01%	861
2022 Q1	$1.08M	Buy	110,900 +100,000	+917%	+$966K	﹤0.01%	902
2021 Q4	$107K	Hold	10,900	–	–	﹤0.01%	1322
2021 Q3	$107K	Buy	+10,900	New	+$108K	﹤0.01%	1136

Toronto Dominion Bank's DALS Position: Q3 2023 in Review

Toronto Dominion Bank sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 110,900 shares — an estimated $1.14M sold.

Toronto Dominion Bank first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $1.14M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Toronto Dominion Bank reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Toronto Dominion Bank sold 110,900 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $1.14M.
Toronto Dominion Bank first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 8 quarters.
Toronto Dominion Bank's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $1.14M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Toronto Dominion Bank's 13F filing for Q3 2023, filed 14 Nov 2023.